[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-341137-105":59,"doc-detail-341137-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","identification-and-validation-of-a-novel-predictive-signature-based-on-hepatocyte-specific-genes-in-hepatocellular-carcinoma-research-open-access","Identification and validation of a novel predictive signature based on hepatocyte-specific genes in hepatocellular carcinoma - Research Open Access","","Hepatocellular carcinoma remains a major cause of cancer-related death, with survival rates that are still unsatisfactory despite multiple treatment options. This study develops and validates a novel predictive signature using hepatocyte-specific genes derived from integrated single-cell and bulk RNA sequencing analyses. Public cohorts including GSE115469, CNP0000650, TCGA, ICGC, and GSE135631 support discovery and validation, while immune infiltration, immunotherapy response, mutations, tumor mutation burden, drug sensitivity, and functional enrichment are assessed across risk scores. Results indicate robust prognostic stratification and potential links to immune microenvironment modulation.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/identification-and-validation-of-a-novel-predictive-signature-based-on-hepatocyte-specific-genes-in-hepatocellular-carcinoma-research-open-access/341137/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/identification-and-validation-of-a-novel-predictive-signature-based-on-hepatocyte-specific-genes-in-hepatocellular-carcinoma-research-open-access/341137.png","ImageObject",300,407,{"name":92,"@type":93},"Aurora","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the purpose of the study on hepatocellular carcinoma?","Question",{"text":112,"@type":113},"To explore novel biomarkers and establish a predictive signature based on hepatocyte-specific genes, integrating single-cell and bulk RNA sequencing profiles.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which datasets are used to develop and validate the predictive signature?",{"text":117,"@type":113},"Discovery and evaluation use GSE115469 and CNP0000650 for single-cell analysis, and TCGA and ICGC for signature development and evaluation, with validation using GSE135631.",{"name":119,"@type":110,"acceptedAnswer":120},"How does the predictive signature relate to prognosis and immune characteristics?",{"text":121,"@type":113},"The high-risk group shows higher risk scores and poorer prognosis, with increased mutation frequency and greater likelihood of benefiting from immunotherapy; immune microenvironment modulation and anti-tumor immune response are suggested by the analyses.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},341137,1790520632,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},4810365810221,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","He etal. BMC Medical Genomics (2024) 17:103 BMC Medical Genomics  \n[https://doi.org/10.1186/s12920-024-01871-1](https://doi.org/10.1186/s12920-024-01871-1)  \nRESEARCH Open Access  \nIdentification and validation of a novel   predictive signature based on hepatocytespecific genes in hepatocellular carcinoma by integrated analysis of single-cell and bulk RNA sequencing  \nYujian He 1, Wei Qi 1, Xiaoli Xie 1 and Huiqing Jiang 1*  \nAbstract  \nBackground Hepatocellular carcinoma represents a significant global burden in terms of cancer-related mortality, posing a substantial risk to human health. Despite the availability of various treatment modalities, the overall survival rates for patients with hepatocellular carcinoma remain suboptimal. The objective of this study was to explore the potential of novel biomarkers and to establish a novel predictive signature utilizing multiple transcriptome profiles. Methods The GSE115469 and CNP0000650 cohorts were utilized for single cell analysis and gene identification. The Cancer Genome Atlas (TCGA) and International Cancer Genome Consortium (ICGC) datasets were utilized in the development and evaluation of a predictive signature. The expressions of hepatocyte-specific genes were further validated using the GSE135631 cohort. Furthermore, immune infiltration results, immunotherapy response prediction, somatic mutation frequency, tumor mutation burden, and anticancer drug sensitivity were analyzed based on various risk scores. Subsequently, functional enrichment analysis was performed on the differential genes identified in the risk model. Moreover, we investigated the expression of particular genes in chronic liver diseases utilizing datasets GSE135251 and GSE142530 .  \nResults Our findings revealed hepatocyte-specific genes (ADH4, LCAT) with notable alterations during cell maturation and differentiation, leading to the development of a novel predictive signature. The analysis demonstrated the efficacy of the model in predicting outcomes, as evidenced by higher risk scores and poorer prognoses in the high-risk group. Additionally, a nomogram was devised to forecast the survival rates of patients at 1, 3, and 5 years. Our study demonstrated that the predictive model may play a role in modulating the immune microenvironment and impacting the anti-tumor immune response in hepatocellular carcinoma. The high-risk group exhibited a higher frequency of mutations and was more likely to benefit from immunotherapy as a treatment option. Additionally, we  \n*Correspondence: Huiqing Jiang [jianghq@hebmu.edu.cn](jianghq@hebmu.edu.cn)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/l](http://creativecommons.org/l)icenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ([http://creativecommons.org/publicdomain/zero/1.0/](http://creativecommons.org/publicdomain/zero/1.0/)) applies to the data made available in this article, unless otherwise stated in a credit line to the data.  \nHe et al. BMC Medical Genomics (2024) 17:103 Page 2 of 19  \nconfirmed that the downregulation of hepatocyte-specific genes may indicate the progression of","cbCaicLtXYCqTA9w","https://ap.wps.com/l/cbCaicLtXYCqTA9w","pdf",14469618,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What is the purpose of the study on hepatocellular carcinoma?\",\"answer\":\"To explore novel biomarkers and establish a predictive signature based on hepatocyte-specific genes, integrating single-cell and bulk RNA sequencing profiles.\"},{\"question\":\"Which datasets are used to develop and validate the predictive signature?\",\"answer\":\"Discovery and evaluation use GSE115469 and CNP0000650 for single-cell analysis, and TCGA and ICGC for signature development and evaluation, with validation using GSE135631.\"},{\"question\":\"How does the predictive signature relate to prognosis and immune characteristics?\",\"answer\":\"The high-risk group shows higher risk scores and poorer prognosis, with increased mutation frequency and greater likelihood of benefiting from immunotherapy; immune microenvironment modulation and anti-tumor immune response are suggested by the analyses.\"}]","Identification and validation of a novel predictive signature based on hepatocyte-specific genes in hepatocellular carcinoma - Research Open Access | PDF",1790040520,48,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/98298ca6495d5f1074be09ca0cbc2ae4.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8b6e93bf09aff6623b459e2dcbf47fae.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b8591aab640a43a9334ab75063677442.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a95f16cbc40c624fa0411da863ad2072.webp",980,1306]